Guitarist Dave Stryker’s new album, “Stryker with Strings Goes to the Movies,” is so enjoyable that when I was told he was coming to Birdland, I was hoping he’d launch it by bringing in the same ...
Now Dave Stryker has thrown his guitar pick into the ring with his superb new album—Stryker With Strings: Goes to the Movies (Strikezone). Dave has a smart, sure attack on guitar that is firm and ...
Inspired by their 2023 Emmy-winning PBS special Wes Montgomery at 100: A 100th Birthday Tribute Concert, guitarist Dave Stryker and arranger and conductor Brent Wallarab decided to explore their ...
Argus analyst David Toung raised the firm’s price target on Stryker (SYK) to $450 from $410 and keeps a Buy rating on the shares. Argus expects ...
WPSU is proud to present special programming to commemorate Black History Month, as part of its commitment to celebrating the ...
In this article, we are going to take a look at where Stryker Corporation (NYSE ... the food and beverage market. David, that area is just wasteland.” He shared that safety isn’t on investors ...
According to the Ukrainian troops the Stryker's mounted machine gun had no ... In words reported by the Daily Telegraph, war correspondent David Axe claimed that the troops could have been ...
The Stryker Johnston Foundation Board of Directors has announced William Buster as the organization’s next executive director. Buster will join the Kalamazoo organization and work toward changing the ...
Cramer commented on the news: “And David, by the way, Stryker, wow. This is gonna be Stryker able to get beyond what it’s doing with just the head and shoulders, knees and toes! Knees and toes!
Cramer commented on the news: “And David, by the way, Stryker, wow. This is gonna be Stryker able to get beyond what it’s doing with just the head and shoulders, knees and toes! Knees and toes!
Chas. Floyd Johnson is the executive producer for the long-running CBS TV series “NCIS” and won an Emmy for his work on “The ...
Argus Research analyst David Toung maintained a Buy rating on Johnson & Johnson (JNJ – Research Report) yesterday. The company’s shares ...